Stephen Mawer - Calumet Specialty Independent Director of Calumet GP, LLC
| CLMT Stock | USD 21.38 0.45 2.06% |
Director
Mr. Stephen P. Mawer is Independent Director of Calumet GP, LLC., the general partner of Calumet Specialty Products Partners, L.P. He retired as President of Koch Supply Trading in 2014 following a 27year career in commodities trading, risk management and refining operations. While at Koch, Mr. Mawer led global commodities trading and served as a senior member of the Koch Industries management team. During his 18year career at Koch, Mr. Mawer successfully managed businesses engaged in the trading of crude oil, refined products, base metals, tanker freight, LNG and biofuels. Mr. Mawer also had responsibility for leading operations at the 80, 000 bpd inRotterdam, Netherlandsrefinery, which generated positive returns during his tenure. Earlier in his career, he held roles in crude oil trading at Ashland Petroleum, RWE AG and Shell since 2016.
| Age | 59 |
| Tenure | 8 years |
| Phone | 317-328-5660 |
| Web | https://calumet.com |
Stephen Mawer Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stephen Mawer against Calumet Specialty stock is an integral part of due diligence when investing in Calumet Specialty. Stephen Mawer insider activity provides valuable insight into whether Calumet Specialty is net buyers or sellers over its current business cycle. Note, Calumet Specialty insiders must abide by specific rules, including filing SEC forms every time they buy or sell Calumet Specialty'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stephen Mawer over two weeks ago Disposition of 15037 shares by Stephen Mawer of Calumet Specialty at 17.87 subject to Rule 16b-3 |
Calumet Specialty Management Efficiency
The company has return on total asset (ROA) of 0.0167 % which means that it generated a profit of $0.0167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.7222) %, meaning that it created substantial loss on money invested by shareholders. Calumet Specialty's management efficiency ratios could be used to measure how well Calumet Specialty manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Dan Smith | Magnolia Oil Gas | 74 | |
| Lee Canaan | PHX Minerals | 64 | |
| Peter Ryalls | GeoPark | 62 | |
| Somit Varma | GeoPark | 59 | |
| William Davis | CNX Resources Corp | 75 | |
| Edward Djerejian | Magnolia Oil Gas | 82 | |
| Clayton Woodrum | Ring Energy | 78 | |
| Paul Westerman | Gulfport Energy Operating | 63 | |
| Maureen LallyGreen | CNX Resources Corp | 71 | |
| Anthony Petrelli | Ring Energy | 66 | |
| Peter Delaney | PHX Minerals | 67 | |
| Pedro Chiorrini | GeoPark | 60 | |
| Tyler Lewis | CNX Resources Corp | N/A | |
| Ian McGuire | CNX Resources Corp | 42 | |
| Stanley McCabe | Ring Energy | 86 | |
| Arcilia Acosta | Magnolia Oil Gas | 55 | |
| John Pinkerton | PHX Minerals | 66 | |
| Constantin Papadimitriou | GeoPark | 58 | |
| Robert Bedingfield | GeoPark | 71 | |
| Carlos Gulisano | GeoPark | 69 | |
| Bernard Lanigan | CNX Resources Corp | 73 | |
Management Performance
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0167 |
Calumet Specialty Leadership Team
Elected by the shareholders, the Calumet Specialty's board of directors comprises two types of representatives: Calumet Specialty inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Calumet. The board's role is to monitor Calumet Specialty's management team and ensure that shareholders' interests are well served. Calumet Specialty's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Calumet Specialty's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Hodges, Alpha IR | ||
| Louis Borgmann, CEO President | ||
| Marc Lawn, LLC GP | ||
| Vincent Donargo, Chief Officer | ||
| Brad McMurray, Director Relations | ||
| David Lunin, Executive CFO | ||
| Stephen Mawer, Independent Director of Calumet GP, LLC | ||
| Scott Obermeier, LLC GP | ||
| Gregory Morical, General VP | ||
| John Kompa, Director Relations | ||
| Bruce Fleming, Executive Vice President - Strategy and Growth of Calumet GP, LLC | ||
| Ryan Willman, LLC GP |
Calumet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Calumet Specialty a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0167 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 3.94 B | ||||
| Shares Outstanding | 85.9 M | ||||
| Shares Owned By Insiders | 21.24 % | ||||
| Shares Owned By Institutions | 37.43 % | ||||
| Number Of Shares Shorted | 5.37 M | ||||
| Price To Earning | 286.67 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.